An oral Covid-19 tablet could generate $10 billion annual revenues says Jefferies
Thursday 07 Oct 2021 Author: Martin Gamble
Shares in Covid-19 vaccine makers Moderna and BioNTech lost around a quarter of their market value in the first two trading days of October after pharmaceutical company Merck released positive data for its oral Covid-19 tablet known as molnupiravir. The tablet, taken twice daily over a five-day course, reduced the risk of hospitalisation by 50% in patients with mild-to-moderate cases of Covid-19. Merck and partner Ridgeback Biotherapeutics said they...